Researchers identified a specific cluster of brain cells on August 29, 2026, that acts as a 'brake' to potentially switch off chronic nerve pain.
The study, conducted on mice, demonstrates how these cells can flip from pain generators to pain relievers, offering a novel target for future therapies.
This breakthrough provides hope for treating neuropathic pain, with clinical trials expected to explore how this mechanism can be safely activated in humans.